HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lars Wallentin Selected Research

Ticagrelor

10/2015Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
8/2015Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.
6/2015Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
6/2015Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
2/2015Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.
11/2014Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes.
8/2014Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.
7/2014Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
6/2014The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.
6/2014Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Lars Wallentin Research Topics

Disease

108Acute Coronary Syndrome
10/2015 - 06/2002
106Myocardial Infarction
12/2015 - 02/2002
99Hemorrhage
12/2015 - 05/2002
95Stroke (Strokes)
01/2016 - 05/2004
64Atrial Fibrillation
01/2016 - 05/2003
39Embolism (Embolus)
01/2016 - 09/2009
38Coronary Artery Disease (Coronary Atherosclerosis)
06/2015 - 05/2002
24Thrombosis (Thrombus)
01/2015 - 05/2002
19Heart Failure
06/2015 - 06/2002
12Inflammation
11/2014 - 12/2003
10Ischemia
02/2013 - 07/2003
10Unstable Angina
01/2013 - 05/2002
9Cardiovascular Diseases (Cardiovascular Disease)
09/2014 - 01/2004
9Diabetes Mellitus
04/2014 - 06/2002
6Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2015 - 05/2006
6Atherosclerotic Plaque (Atheroma)
06/2015 - 05/2002
6Transient Ischemic Attack
06/2015 - 02/2010
6Heart Diseases (Heart Disease)
02/2015 - 04/2007
6Hypertension (High Blood Pressure)
01/2015 - 02/2010
6Kidney Diseases (Kidney Disease)
03/2014 - 09/2010
4Body Weight (Weight, Body)
07/2014 - 07/2003
4Coronary Disease (Coronary Heart Disease)
05/2014 - 05/2002
3Dyspnea (Shortness of Breath)
10/2015 - 12/2011
3Infection
11/2014 - 10/2012
3Death (Near-Death Experience)
01/2014 - 02/2012
3Chest Pain (Chest Pains)
07/2010 - 02/2007
2Chronic Obstructive Pulmonary Disease (COPD)
01/2016 - 10/2015
2Pulmonary Embolism
12/2015 - 02/2012
2Sudden Death
11/2014 - 10/2012
2Myocardial Ischemia (Ischemic Heart Diseases)
11/2014 - 02/2010
2Obesity
09/2013 - 08/2013
2Heart Arrest (Cardiac Arrest)
02/2012 - 05/2011
2Necrosis
05/2010 - 12/2003
2Reperfusion Injury
12/2007 - 02/2007
1AIDS-Related Complex (ARC)
08/2015
1Hypothermia
06/2015
1Peripheral Arterial Disease
06/2015

Drug/Important Bio-Agent (IBA)

58clopidogrel (Plavix)FDA Link
10/2015 - 05/2003
57Warfarin (Coumadin)FDA LinkGeneric
01/2016 - 05/2003
45TicagrelorIBA
10/2015 - 04/2009
35apixabanIBA
01/2016 - 06/2009
29Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2015 - 02/2002
21Biological Markers (Surrogate Marker)IBA
12/2015 - 07/2003
20Brain Natriuretic Peptide (Natrecor)FDA Link
12/2015 - 07/2003
17Dalteparin (Dalteparin Sodium)FDA Link
02/2012 - 05/2002
15pro-brain natriuretic peptide (1-76)IBA
12/2015 - 07/2003
15TroponinIBA
12/2015 - 05/2002
13CreatinineIBA
06/2015 - 06/2002
13Growth Differentiation Factor 15IBA
11/2014 - 02/2007
13Troponin T (T, Troponin)IBA
01/2014 - 05/2002
11Vitamin KFDA Link
06/2015 - 05/2009
11Troponin IIBA
02/2015 - 06/2003
11Enoxaparin (Lovenox)FDA LinkGeneric
02/2010 - 08/2003
10C-Reactive ProteinIBA
12/2015 - 03/2003
10Cystatin CIBA
12/2015 - 10/2004
10Heparin (Liquaemin)FDA LinkGeneric
02/2008 - 02/2002
9Thrombin Receptors (Thrombin Receptor)IBA
06/2015 - 01/2012
9AnticoagulantsIBA
04/2015 - 04/2006
9fondaparinux (Arixtra)FDA Link
02/2015 - 12/2005
9ThrombinFDA Link
12/2013 - 05/2002
8prasugrelIBA
08/2012 - 05/2006
6Glycoproteins (Glycoprotein)IBA
05/2015 - 10/2002
6Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
02/2015 - 05/2002
6dabigatran etexilateIBA
02/2014 - 04/2012
5Fibrinolytic Agents (Antithrombotic Agents)IBA
06/2015 - 05/2004
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2015 - 01/2004
5Factor Xa (Coagulation Factor Xa)IBA
09/2011 - 12/2005
5tenecteplaseFDA Link
05/2006 - 08/2003
5abciximab (ReoPro)FDA Link
06/2004 - 08/2003
4Interleukin-6 (Interleukin 6)IBA
12/2015 - 12/2003
4LDL CholesterolIBA
06/2015 - 03/2006
4Lipoproteins (Lipoprotein)IBA
06/2015 - 03/2006
4Trinitrotoluene (TNT)IBA
01/2014 - 03/2003
4Triglycerides (Triacylglycerol)IBA
11/2013 - 03/2006
3PAR-1 ReceptorIBA
01/2015 - 08/2014
31-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
05/2014 - 03/2006
3darapladibIBA
05/2014 - 10/2010
3ximelagatran (Exanta)IBA
03/2007 - 09/2003
2Platelet Membrane Glycoprotein IIbIBA
05/2015 - 10/2002
2CholesterolIBA
11/2013 - 03/2006
2HDL CholesterolIBA
11/2013 - 03/2006
2Natriuretic PeptidesIBA
06/2013 - 09/2004
2omega-Chloroacetophenone (Mace)IBA
06/2013 - 10/2010
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2010 - 12/2004
2Transforming Growth Factor beta (TGF-beta)IBA
12/2007 - 02/2007
2fibrin fragment D (D-dimer)IBA
03/2007 - 02/2002
2Thromboplastin (Tissue Factor)IBA
03/2007 - 12/2005
2oxidized low density lipoproteinIBA
11/2006 - 03/2006
1IceIBA
06/2015
1Glucose (Dextrose)FDA LinkGeneric
06/2015
1Caspase 1 (ICE Protease)IBA
06/2015
1Interleukin-18 (Interleukin 18)IBA
06/2015

Therapy/Procedure

14Stents
01/2015 - 03/2007
11Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2015 - 05/2004
9Intensive Care (Surgical Intensive Care)
11/2013 - 10/2004
7Transplants (Transplant)
06/2015 - 10/2010
4Catheters
06/2015 - 10/2007
3Drug-Eluting Stents
09/2014 - 03/2007
3Thrombolytic Therapy
02/2008 - 04/2003
2Angioplasty (Angioplasty, Transluminal)
10/2010 - 02/2006